Glenmark Pharmaceuticals Ltd. share price target

Name: Latest research reports of Glenmark Pharmaceuticals Ltd. authored by Ashika Research and published by - Trendlyne research reports.
Item: Glenmark Pharmaceuticals Ltd.
Rating: 5
Author: Ashika Research

Glenmark Pharmaceuticals Ltd. has an average share price target of 2144. The consensus estimate represents an upside of 2.82% from the last price of 2085.20. View 11 reports from 5 analysts offering long-term price targets for Glenmark Pharmaceuticals Ltd..

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Load latest Google or static link led you to an intermediate page.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
21 Sep 2025	Glenmark Pharma	Consensus Share Price Target	2085.20	2254.50	-	8.12	buy	pdf Detailed Estimates
27 Sep 2013	Glenmark Pharma	Ashika Research	2085.20	610.00	522.85 (298.81%)	Target met	Buy	pdf post cache	Broker Report Glenmark Pharma Limited Ashika Research Glenmark pharma's (GNP) Q1FY14 revenues grew 19% YoY to Rs. 1238.2 cr driven by 33% growth in Latin America (specialty business), 25% growth in RoW markets, 26% growth in API... pdf Copy Link Share on Share on Share on Share on Alert
15 May 2012	Glenmark Pharma	Ashika Research	2085.20	410.00	365.35 (470.74%)	Target met	Buy	pdf post cache	Broker Report Glenmark Pharmaceuticals Ltd Ashika Research Glenmark Pharmaceuticals Ltd(GPL) is a research driven, integrated pharma company that has presence in both Generic and API business. The company is a leading player in the discovery of new molecules both new chemical... pdf Copy Link Share on Share on Share on Share on Alert

* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.

63.48% Gain from 52W Low

Glenmark Pharmaceuticals Ltd. share price target

Glenmark Pharmaceuticals Ltd. has an average share price target of 2144. The consensus estimate represents an upside of 2.82% from the last price of 2085.20. View 11 reports from 5 analysts offering long-term price targets for Glenmark Pharmaceuticals Ltd..

Glenmark Pharma Limited

Glenmark Pharmaceuticals Ltd

Advisor Screeners